0001127602-21-012752.txt : 20210402
0001127602-21-012752.hdr.sgml : 20210402
20210402171455
ACCESSION NUMBER: 0001127602-21-012752
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210331
FILED AS OF DATE: 20210402
DATE AS OF CHANGE: 20210402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paulson John
CENTRAL INDEX KEY: 0001394923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 21802882
MAIL ADDRESS:
STREET 1: 1133 AVENUE OF THE AMERICAS
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-03-31
0000885590
Bausch Health Companies Inc.
BHC
0001394923
Paulson John
1251 AVENUE OF THE AMERICAS
NEW YORK
NY
10020
1
Common Shares, No Par Value
2021-03-31
4
A
0
952
31.74
A
74392
D
Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.
/s/ Kirsten O'Donnell, attorney-in-fact for John Paulson
2021-04-02